Levi & Korsinsky Reminds Applied Therapeutics, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - APLT
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Applied Therapeutics, Inc. (NASDAQ:APLT) for potential violations of federal securities laws. This follows the FDA's issuance of a Complete Response Letter for the company's new drug application for govorestat.
December 15, 2024 | 6:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Applied Therapeutics is under investigation for potential securities law violations after the FDA issued a Complete Response Letter for its drug govorestat.
The investigation by Levi & Korsinsky into potential securities law violations is significant, as it could lead to legal challenges and affect investor confidence. The FDA's Complete Response Letter indicates regulatory hurdles for govorestat, potentially impacting the company's future revenue and stock price negatively in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100